← Evidence map

ArticleBone2017

Corrigendum to "SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice" [Bone 82 (2016) 101-107].

Kathryn M Thrailkill et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2016

2017

2018

2019

2020

2021

this paperpooled itcites it

Corrigendum to "SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice" [Bone 82 (2016) 101-107]. | OpenQuestion